View of Development and Validation of a Stability-Indicating RP-HPLC Method for the Quantitative Estimation of Omaveloxolone (First FDA-Approved Drug in Friedreich Ataxia) in Bulk and Pharmaceutical Formulations

Return to Article Details Development and Validation of a Stability-Indicating RP-HPLC Method for the Quantitative Estimation of Omaveloxolone (First FDA-Approved Drug in Friedreich Ataxia) in Bulk and Pharmaceutical Formulations Download Download PDF